Verastem reported $0 in Cost of Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US 237K 27K
Abbvie ABBV:US $ 4142M 121M
AstraZeneca AZN:LN 1904M 375M
Curis CRIS:US $ 0.04M 0.04M
Epizyme EPZM:US $ 2.64M 516K
Gilead Sciences GILD:US $ 1442M 18M
Laboratory Of America LH:US $ 2574.2M 92.5M
Novartis NOVN:VX SF 3749M 6M
Pfizer PFE:US $ 8671M 1339M
YTE INCY:US $ 45.24M 8.02M